Filing Flows

Filing Flows › C4 Therapeutics (CCCC) › Who owns the stock

Who owns C4 Therapeutics (CCCC) stock

143 funds reported C4 Therapeutics (CCCC) shares in their latest 13F filings, worth $527M in all. The largest holder is Morgan Stanley ($41.4M). Last quarter 97 funds added to their stakes and 51 cut them.

Largest holders of CCCC (13F)Largest holders of CCCC (13F)Morgan Stanley$41.4MRA Capital Management, L.P.$37.4MBlackRock$36.9MLynx1 Capital Management LP$34.2MSquadron Capital Management LLC$33.6MBain Capital Life Sciences Invest…$33.5MVanguard Capital Management LLC$20.6MCitadel Advisors LLC$19.6MGoldman Sachs Group$16.5MTwo Sigma Investments, LP$16.2M

Largest holders (13F)

FundSharesValueChangeQuarter
Morgan Stanley8,867,338$41.4Mdecrease2026-06-30
RA Capital Management, L.P.8,000,000$37.4Munchanged2026-06-30
BlackRock7,896,718$36.9Mincrease2026-06-30
Lynx1 Capital Management LP7,326,691$34.2Mincrease2026-06-30
Squadron Capital Management LLC7,200,000$33.6Mincrease2026-06-30
Bain Capital Life Sciences Investors, LLC7,171,910$33.5Munchanged2026-06-30
Vanguard Capital Management LLC4,417,731$20.6Mincrease2026-06-30
Citadel Advisors LLC4,187,580$19.6Mincrease2026-06-30
Goldman Sachs Group3,530,991$16.5Mincrease2026-06-30
Two Sigma Investments, LP3,469,707$16.2Mincrease2026-06-30
Soleus Capital Management, L.P.3,377,981$15.8Mdecrease2026-06-30
Silverarc Capital Management, LLC3,032,060$14.2Mincrease2026-06-30
Wasatch Advisors LP4,160,048$13.9Mincrease2026-09-30
Bank of America2,656,359$12.4Mincrease2026-06-30
Geode Capital Management, LLC2,522,163$11.8Mincrease2026-06-30

C4 Therapeutics' latest quarter

C4 Therapeutics, Q3 2026: revenue $8.5M (-25% year over year), operating margin -290.5%, net loss $21.8M, operating cash flow −$26.0M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most CCCC stock?

By the latest 13F filings: Morgan Stanley ($41.4M); RA Capital Management, L.P. ($37.4M); BlackRock ($36.9M); Lynx1 Capital Management LP ($34.2M); Squadron Capital Management LLC ($33.6M).

What is the short interest in CCCC?

42,722,018 shares were sold short at the 2026-10-15 settlement, 5.76% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.